Warc anticipates global adspend growth this year to ring in at a healthy 4.7%, or $572bn (£410bn).
Not only isn't print dead, as ahead-of-themselves media wonks have claimed for the past decade, but it's thriving in a most unlikely environment: the point of care
Next year will be the start of the shift from marketing algorithms to AI, predicts Kantar Millward Brown.
GroupM, the media investment arm of WPP, forecasts global ad growth of 4.3% in 2018, and predicts Google and Facebook will strengthen their stranglehold on digital advertising.
In a follow-up to last year's media report, the Association of National Advertisers details "dysfunction" and rigged bids.
Biogen reports better-than-expected Spinraza sales; FDA to discuss opioid prescriptions with payers; UnitedHealth Group launches media review
In apportioning their media budgets, pharma companies continue to straddle the line between new and traditional strategies.
Drugmakers are becoming much more cautious with their budgets, WebMD executives said.
WPP's acquisition of CMI, a significant player in the healthcare media-planning space, will likely bolster the services it provides to pharma clients.
Interpublic's dedicated group extended its brief beyond North America.
The agency plans to use health outcomes data to better inform pharmaceutical marketing strategies.